-
681
Hypophyseal Involvement in Immunoglobulin G4-Related Disease: A Retrospective Study from a Single Tertiary Center
Published 2018-01-01“…With GC and/or immunosuppressant treatment, however, pituitary function or diabetes insipidus did not improve considerably.…”
Get full text
Article -
682
Role of Myokines in Myositis Pathogenesis and Their Potential to be New Therapeutic Targets in Idiopathic Inflammatory Myopathies
Published 2020-01-01“…Many patients, even after immunosuppressive therapy, do not respond to treatment, so new alternatives have been sought for this. …”
Get full text
Article -
683
Actinomyces Acute Rhinosinusitis Complicated by Subperiosteal Abscess in an Immunocompromised 12-Year-Old: Case Report and Literature Review
Published 2022-01-01“…Our case is the first reported in a pediatric patient and the first taking immunosuppressive medication. Overall, only 3 cases of actinomyces rhinosinusitis in immunosuppressed individuals have been reported, each with uncontrolled diabetes and each also responded well to surgery and appropriate antibiotics. …”
Get full text
Article -
684
Role of T Regulatory Cells and Myeloid-Derived Suppressor Cells in COVID-19
Published 2022-01-01“…In conclusion, further studies are required to investigate the role and function of immunosuppressive cells and their potentials as prognostic biomarkers and therapeutic targets in COVID-19 patients.…”
Get full text
Article -
685
Polyoma BK Virus: An Oncogenic Virus?
Published 2013-01-01“…He subsequently developed BK virus nephropathy related to chronic immunosuppressant therapy. Three years later, misfortune struck again, and he developed adenocarcinoma of the bladder.…”
Get full text
Article -
686
Wernicke’s Encephalopathy: An Unusual Consequence of the Acquired Immune Deficiency Syndrome—Case Report and Literature Review
Published 2013-01-01“…Wernicke’s has been described in patients with acquired immune deficiency syndrome (AIDS); however, given these patients’ immunosuppressed state, the diagnosis of Wernicke’s encephalopathy is not apparent. …”
Get full text
Article -
687
A New Hope in Immunotherapy for Malignant Gliomas: Adoptive T Cell Transfer Therapy
Published 2014-01-01“…Moreover, enhanced biologic functions of T cells generated by genetic engineering and modified immunosuppressive microenvironment of host by homeostatic T cell expansion and/or elimination of immunosuppressive cells and molecules can induce more potent antitumor T cell responses and make this strategy hold promise in promoting a patient response for malignant glioma treatment. …”
Get full text
Article -
688
Acknowledging and addressing real-world challenges to treating immune-related adverse events
Published 2024-07-01“…Currently, irAE treatment remains suboptimal in many areas, as many expert guidelines remain vague on the optimal selection, dosing, and duration of steroids and the use of other immunosuppressive agents. This coupled with delays in diagnosis and difficulties for patients accessing effective irAE treatment results in barriers to effective irAE care. …”
Get full text
Article -
689
It’s about TIME – Gal-9 as a potential immunotherapeutic target in pancreatic ductal adenocarcinoma
Published 2025-01-01“…Gal-9 significantly contributes to the immunosuppressive milieu of PDAC by interacting with various immune cells, such as T cells, macrophages, and myeloid-derived suppressor cells (MDSCs). …”
Get full text
Article -
690
Immunomodulatory Effect of Bisphosphonate Risedronate Sodium on CD163+ Arginase 1+ M2 Macrophages: The Development of a Possible Supportive Therapy for Angiosarcoma
Published 2013-01-01“…An imbalance of immunosuppressive cells and cytotoxic cells plays an important role in inhibiting the antitumor immune response of the tumor-bearing host. …”
Get full text
Article -
691
Application of Corticosteroids in Dentistry: A Review
Published 2024-12-01“…Corticosteroids are crucial in dentistry for their anti-inflammatory and immunosuppressive properties, aiding in managing conditions such as oral lichen planus, recurrent aphthous stomatitis, and post-operative inflammation. …”
Get full text
Article -
692
Leclercia adecarboxylata Musculoskeletal Infection in an Immune Competent Pediatric Patient: An Emerging Pathogen?
Published 2015-01-01“…Leclercia adecarboxylata has increasing reports in immunosuppressed and adult patients with musculoskeletal infection. …”
Get full text
Article -
693
Invasive Group B Streptococcal Disease in Two Pediatric Patients with Systemic Lupus Erythematosus
Published 2013-01-01“…We report two patients with SLE who were treated with steroids and immunosuppressive medication and then developed invasive Group B Streptococcus (GBS) infections. …”
Get full text
Article -
694
Real-world treatment patterns and clinical characteristics in patients with moderate-to-severe systemic lupus erythematosus: an analysis of the SLE Prospective Observational Cohort...
Published 2025-01-01“…Disease activity (SLE Disease Activity Index 2000 (SLEDAI-2K)), average oral glucocorticoid dose and use of other treatments—specifically antimalarials, biologics and immunosuppressants—were measured over time. Subgroup analyses were stratified by baseline interferon gene signature (IFNGS) status and disease activity (SLEDAI-2K) status.Results Patient demographics and baseline characteristics were similar among subgroups; the majority of patients were on antimalarials (n=670; 81.1%), followed by glucocorticoids (n=537; 65.0%), immunosuppressants (n=453; 54.8%) and biologics (n=175; 21.2%). …”
Get full text
Article -
695
Unveiling immune cell response disparities in human primary cancer-associated fibroblasts between two- and three-dimensional cultures.
Published 2024-01-01“…Notably, 3D CAF-secreted proteins manifest a more immunosuppressive profile by enhancing monocyte transendothelial migration and differentiation into M2-like tumor-associated macrophages (TAMs). …”
Get full text
Article -
696
Anti-Factor H Antibodies in Egyptian Children with Hemolytic Uremic Syndrome
Published 2021-01-01“…All patients who started immunosuppressives early together with plasmapheresis upon detection of their anti-FH had complete renal function recovery. …”
Get full text
Article -
697
Infections in systemic lupus erythematosus: A study of incidence and risk factors in 100 patients from western India
Published 2022-01-01“…Management of SLE needs vigilance for infection and judicious use of immunosuppressive drugs.…”
Get full text
Article -
698
Cost-Effectiveness of Extracorporeal Photopheresis in Patients With Chronic Graft-vs-Host Disease
Published 2024-02-01“…The analysis considered costs of second-line treatment and disease management including immunosuppressants, hospitalizations and subsequent therapy. …”
Get full text
Article -
699
Vascular Endograft Infection with Listeria monocytogenes reated with Surgical Debridement but without Graft Removal
Published 2011-01-01“…The awareness of Listeria monocytogenes as a pathogen in meningitis and bacteremia in immunosuppressed patients is high. We report a case of vascular graft infection due to Listeria monocytogenes as an example of a less well-known manifestation of listeriosis and focus on the possible treatment procedures emphasizing a management with surgical debridement but preservation of the endograft, in contrast to the gold standard treatment of vascular graft infections which consists of a removal of the graft.…”
Get full text
Article -
700
Inflammatory demyelinating polyneuropathies and patient management during the COVID-19 pandemic. Literature review
Published 2020-06-01“…They can cause a lot of difficulties in daily practice due to their clinical heterogeneity and long term immunosuppressive treatment. Environmental and epidemiological changes may increase the incidence of the demyelinating polyneuropathies. …”
Get full text
Article